Bethany Niell, MD, PhD

Cancer Focus:
Breast Cancer, Ductal Carcinoma In Situ, Inflammatory Breast Cancer, Invasive Ductal Carcinoma, Triple Negative Breast Cancer

Dr. Niell received her MD and PhD degrees from the University of Michigan. She completed a Diagnostic Radiology Residency at Massachusetts General Hospital, where she also served as Chief Resident. Dr. Niell is a board-certified subspecialty-trained diagnostic radiologist. Her clinical practice involves interpreting mammograms, ultrasound, breast MRI and performing image-guided breast biopsies. Dr. Niell is especially interested in the appropriate utilization of breast imaging, including breast MRI, mammography, and tomosynthesis, based on her background in public health.

Education & Training

Residency:

• Massachusetts General Hospital - Diagnostic Radiology

Medical School:

• University of Michigan, School of Medicine - MD

• Byrd C, Kingsbury C, Niell B, Funaro K, Bhatt A, Weinfurtner RJ, Ataya D. Appropriateness of acute breast symptom recommendations provided by ChatGPT. Clin Imaging. 2025 Sep.125:110549. Pubmedid: 40540768.
• Soliman H, Aldrich A, Abdo N, Han H, Soyano A, Costa R, Armaghani A, Kiluk J, Khakpour N, Lee MC, Hoover S, Laronga C, Niell B, Mooney B, Weinfurtner RJ, Rosa M, Czerniecki B. A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer. NPJ Breast Cancer. 2025 Mar.11(1):29. Pubmedid: 40097486. Pmcid: PMC11914126.
• Conley CC, Anderson A, Rodriguez JD, Kang H, Taylor EP, Luck C, Rosas Torres J, Cheraghi N, Newton N, Niell BL, O'Neill SC, Vadaparampil ST. Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study. Breast Cancer Res Treat. 2025 Jan.209(1):61-71. Pubmedid: 39190231. Pmcid: PMC11786993.
• Mayfield JD, Ataya D, Abdalah M, Stringfield O, Bui MM, Raghunand N, Niell B, El Naqa I. Presurgical Upgrade Prediction of DCIS to Invasive Ductal Carcinoma Using Time-dependent Deep Learning Models with DCE MRI. Radiol Artif Intell. 2024 Sep.6(5):e230348. Pubmedid: 38900042. Pmcid: PMC11427917.
• Conley CC, Rodriguez JD, McIntyre M, Niell BL, O'Neill SC, Vadaparampil ST. Strategies for Identifying and Recruiting Women at High Risk for Breast Cancer for Research Outside of Clinical Settings: Observational Study. J Med Internet Res. 2024 Sep.26:e54450. Pubmedid: 39222344. Pmcid: PMC11406107.
• Niell BL, Jochelson MS, Amir T, Brown A, Adamson M, Baron P, Bennett DL, Chetlen A, Dayaratna S, Freer PE, Ivansco LK, Klein KA, Malak SF, Mehta TS, Moy L, Neal CH, Newell MS, Richman IB, Schonberg M, Small W, Ulaner GA, Slanetz PJ. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update. J Am Coll Radiol. 2024 Jun.21(6S):S126-S143. Pubmedid: 38823941.
• Bhatt AA, Niell B. Tumor Doubling Time and Screening Interval. Radiol Clin North Am. 2024 Jul.62(4):571-580. Pubmedid: 38777534.
• Bevers TB, Niell BL, Baker JL, Bennett DL, Bonaccio E, Camp MS, Chikarmane S, Conant EF, Eghtedari M, Flanagan MR, Hawley J, Helvie M, Hodgkiss L, Hoyt TL, Ivanovich J, Jochelson MS, Kulkarni S, Lancaster RB, Mauer C, Maxwell J, Patel BK, Pearlman M, Philpotts L, Plecha D, Plichta JK, Shakeri S, Smith ML, Streibert CL, Strigel RM, Tumyan L, Winkler NS, Wolverton DE, Bergman MA, Kumar R, Stehman K. NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J Natl Compr Canc Ne. 2023 Sep.21(9):900-909. Pubmedid: 37673117.
• Chetlen A, Niell BL, Brown A, Baskies AM, Battaglia T, Chen A, Jochelson MS, Klein KA, Malak SF, Mehta TS, Sinha I, Tuscano DS, Ulaner GA, Slanetz PJ. ACR Appropriateness Criteria® Breast Implant Evaluation: 2023 Update. J Am Coll Radiol. 2023 Nov.20(11S):S329-S350. Pubmedid: 38040459.
• Conley CC, Rodriguez JD, McIntyre M, Brownstein NC, Niell BL, O'Neill SC, Vadaparampil ST. Self-reported barriers to screening breast MRI among women at high risk for breast cancer. Breast Cancer Res Treat. 2023 Nov.202(2):345-355. Pubmedid: 37640965.
• Klein KA, Kocher M, Lourenco AP, Niell BL, Bennett DL, Chetlen A, Freer P, Ivansco LK, Jochelson MS, Kremer ME, Malak SF, McCrary M, Mehta TS, Neal CH, Porpiglia A, Ulaner GA, Moy L. ACR Appropriateness Criteria® Palpable Breast Masses: 2022 Update. J Am Coll Radiol. 2023 May.20(5S):S146-S163. Pubmedid: 37236740.
• Brown T, Schafer L, Qureshi MM, Freer P, Niell BL, Yeh ED, Moy L, Fishman MDC, Slanetz PJ. Current Practices in Anticoagulation Management for Patients Undergoing Percutaneous Image-guided Breast Procedures. J Breast Imaging. 2023 Jun.5(4):445-452. Pubmedid: 37520156. Pmcid: PMC10380696.
• Niell BL. Background Parenchymal Enhancement at Breast MRI: More Is Not Better. Radiology. 2023 Jan.306(1):100-101. Pubmedid: 36040339. Pmcid: PMC9792709.
• Soliman H, Hogue D, Han H, Mooney B, Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Soyano A, Armaghani A, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Laronga C, Rosa M, Khong H, Czerniecki B. Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nat Med. 2023 Feb.29(2):450-457. Pubmedid: 36759673.
• Soliman H, Hogue D, Han H, Mooney B, Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Soyano A, Armaghani A, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Laronga C, Rosa M, Khong H, Czerniecki B. Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nat Med. 2023 Dec.29(12):3270. Pubmedid: 36932246.
• Mehta TS, Lourenco AP, Niell BL, Bennett DL, Brown A, Chetlen A, Freer P, Ivansco LK, Jochelson MS, Klein KA, Malak SF, McCrary M, Mullins D, Neal CH, Newell MS, Ulaner GA, Moy L. ACR Appropriateness Criteria® Imaging After Breast Surgery. J Am Coll Radiol. 2022 Nov.19(11S):S341-S356. Pubmedid: 36436961.
• Weinfurtner RJ, Abdalah M, Stringfield O, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Latifi K, Niell B, Montejo M, Raghunand N. Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2− Breast Cancer Treated With Preoperative Stereotactic Ablative Body Radiotherapy. J Breast Imaging. 2022 May.4(3):273-284. Pubmedid: 36686407. Pmcid: PMC9851176.
• Wang X, Chang MD, Lee MC, Niell BL. The Breast Cancer Screening and Timing of Breast MRI-Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center. Curr Oncol. 2022 Mar.29(3):2119-2131. Pubmedid: 35323371. Pmcid: PMC8947675.
• Weinfurtner RJ, Raghunand N, Stringfield O, Abdalah M, Niell BL, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Montejo M. MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity. Clin Breast Cancer. 2022 Feb.22(2):e214-e223. Pubmedid: 34384695.
• Onishi N, Li W, Newitt DC, Harnish RJ, Strand F, Nguyen AA, Arasu VA, Gibbs J, Jones EF, Wilmes LJ, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard S, Umphrey HR, Nelson MT, Church AL, Bolan PJ, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez Paniagua D, Hardesty L, Brandt KR, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane E, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica LA, Niell B, Drukteinis J, Newell MS, Giurescu ME, Berman E, Lehman CD, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau SH, Chenevert T, Yau C, DeMichele A, Berry DA, Esserman LJ, Hylton NM. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 Nov.301(2):295-308. Pubmedid: 34427465. Pmcid: PMC8574064.
• Brown A, Lourenco AP, Niell BL, Cronin B, Dibble EH, DiNome ML, Goel MS, Hansen J, Heller SL, Jochelson MS, Karrington B, Klein KA, Mehta TS, Newell MS, Schechter L, Stuckey AR, Swain ME, Tseng J, Tuscano DS, Moy L. ACR Appropriateness Criteria® Transgender Breast Cancer Screening. J Am Coll Radiol. 2021 Nov.18(11S):S502-S515. Pubmedid: 34794604.
• Niell BL. Editorial Comment: Barriers and Enabling Factors That Affect Supplemental Screening. Ajr Am J Roentgenol. 2021 Nov.217(5):1080. Pubmedid: 34499531.
• Falcon S, Funaro K, Williams A, Niell BL. Effect of the EQUIP initiative on additional images performed at screening mammography: a pilot study. Clin Imaging. 2021 May.73:13-17. Pubmedid: 33248358.
• Niell BL, Abdalah M, Stringfield O, Raghunand N, Ataya D, Gillies R, Balagurunathan Y. Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk. Ajr Am J Roentgenol. 2021 Jul.217(1):64-75. Pubmedid: 32876474. Pmcid: PMC9801515.
• Niell BL, Augusto B, McIntyre M, Conley CC, Gerke T, Roetzheim R, Garcia J, Vadaparampil ST. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography. Ajr Am J Roentgenol. 2021 Jul.217(1):48-55. Pubmedid: 33978450. Pmcid: PMC9124592.
• Funaro K, Ataya D, Niell B. Understanding the Mammography Audit. Radiol Clin North Am. 2021 Jan.59(1):41-55. Pubmedid: 33222999.
• Soliman H, Hogue D, Han HS, Mooney B, Lima Barros Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Rosa M, Khong H, Czerniecki BJ. A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer. Clin Cancer Res. 2021 Feb.27(4):1012-1018. Pubmedid: 33219014.
• Leong LT, Malkov S, Drukker K, Niell BL, Sadowski P, Wolfgruber T, Greenwood HI, Joe BN, Kerlikowske K, Giger ML, Shepherd JA. Dual-energy three-compartment breast imaging for compositional biomarkers to improve detection of malignant lesions. Commun Med (Lond). 2021 Aug.1:29. Pubmedid: 35602210. Pmcid: PMC9053198.
• Conley CC, Niell BL, Augusto BM, McIntyre M, Roetzheim R, Funaro K, Vadaparampil ST. Uptake of Risk Appropriate Behaviors After Breast Cancer Risk Stratification in the Mammography Screening Population. J Am Coll Radiol. 2020 Oct.17(10):1285-1288. Pubmedid: 32229274. Pmcid: PMC7529655.
• Heller SL, Lourenco AP, Niell BL, Ajkay N, Brown A, Dibble EH, Didwania AD, Jochelson MS, Klein KA, Mehta TS, Pass HA, Stuckey AR, Swain ME, Tuscano DS, Moy L. ACR Appropriateness Criteria® Imaging After Mastectomy and Breast Reconstruction. J Am Coll Radiol. 2020 Nov.17(11S):S403-S414. Pubmedid: 33153553. Pmcid: PMC8173332.
• Li W, Newitt DC, Gibbs J, Wilmes LJ, Jones EF, Arasu VA, Strand F, Onishi N, Nguyen AA, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard SA, Umphrey H, Bernreuter W, Nelson M, Church AL, Bolan P, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez-Paniagua D, Hardesty L, Brandt K, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane EP, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica A, Niell BL, Drukteinis J, Newell MS, Cohen MA, Giurescu M, Berman E, Lehman C, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau S, Chenevert T, Yau C, DeMichele A, Berry D, Esserman LJ, Hylton NM. Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL. NPJ Breast Cancer. 2020 Nov.6(1):63. Pubmedid: 33298938. Pmcid: PMC7695723.
• Funaro K, Prather A, Niell B, Jared Weinfurtner R. Tissue marker migration after MRI-guided breast biopsy: Migration frequency and associated factors. Breast J. 2020 Mar.26(3):440-445. Pubmedid: 31448455.
• Drukker K, Giger ML, Joe BN, Kerlikowske K, Greenwood H, Drukteinis JS, Niell B, Fan B, Malkov S, Avila J, Kazemi L, Shepherd J. Combined Benefit of Quantitative Three-Compartment Breast Image Analysis and Mammography Radiomics in the Classification of Breast Masses in a Clinical Data Set. Radiology. 2019 Mar.290(3):621-628. Pubmedid: 30526359. Pmcid: PMC6394732.
• Ataya D, Niell BL. Complicated Cysts: Should Management Depend Upon Age?. Acad Radiol. 2019 Jul.26(7):907-908. Pubmedid: 30987873.
• Falcon S, Weinfurtner RJ, Mooney B, Niell BL. SAVI SCOUT® localization of breast lesions as a practical alternative to wires: Outcomes and suggestions for trouble-shooting. Clin Imaging. 2019 Jan.52:280-286. Pubmedid: 30193186.
• Roark AA, Dang PA, Niell BL, Halpern EF, Lehman CD. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer. Ajr Am J Roentgenol. 2019 Feb.212(2):271-279. Pubmedid: 30540208.
• Weinfurtner RJ, Niell B, Mekhail Y, Aguila E, Kamat L. Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and Management. Clin Breast Cancer. 2018 Oct.18(5):e1031-e1036. Pubmedid: 29625911.
• Niell BL, Bhatt K, Dang P, Humphrey K. Utility of Breast MRI for Further Evaluation of Equivocal Findings on Digital Breast Tomosynthesis. Ajr Am J Roentgenol. 2018 Nov.211(5):1171-1178. Pubmedid: 30207789.
• Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, Garber JE, Gray R, Greenberg CC, Greenup R, Hansen NM, Harris RE, Heerdt AS, Helsten T, Hodgkiss L, Hoyt TL, Huff JG, Jacobs L, Lehman CD, Monsees B, Niell BL, Parker CC, Pearlman M, Philpotts L, Shepardson LB, Smith ML, Stein M, Tumyan L, Williams C, Bergman MA, Kumar R. Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2018 Nov.16(11):1362-1389. Pubmedid: 30442736.
• Niell BL, Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio-Alexander RM, Heller SL, Holbrook AI, Le-Petross HT, Lewin AA, Mehta TS, Slanetz PJ, Stuckey AR, Tuscano DS, Ulaner GA, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria Evaluation of the Symptomatic Male Breast. J Am Coll Radiol. 2018 Nov.15(11S):S313-S320. Pubmedid: 30392600.
• diFlorio-Alexander RM, Slanetz PJ, Moy L, Baron P, Didwania AD, Heller SL, Holbrook AI, Lewin AA, Lourenco AP, Mehta TS, Niell BL, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria Breast Imaging of Pregnant and Lactating Women. J Am Coll Radiol. 2018 Nov.15(11S):S263-S275. Pubmedid: 30392595.
• Holbrook AI, Moy L, Akin EA, Baron P, Didwania AD, Heller SL, Le-Petross HT, Lewin AA, Lourenco AP, Mehta TS, Niell BL, Slanetz PJ, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria Breast Pain. J Am Coll Radiol. 2018 Nov.15(11S):S276-S282. Pubmedid: 30392596.
• Lourenco AP, Moy L, Baron P, Didwania AD, diFlorio RM, Heller SL, Holbrook AI, Lewin AA, Mehta TS, Niell BL, Slanetz PJ, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria Breast Implant Evaluation. J Am Coll Radiol. 2018 May.15(5S):S13-S25. Pubmedid: 29724416.
• Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol. 2018 Mar.15(3 Pt A):408-414. Pubmedid: 29371086.
• Niell BL. Appropriate Use of Imaging to Detect Primary, Second Primary, and Recurrent Breast Cancer. J Natl Compr Canc Ne. 2018 Jul.16(7):916-918. Pubmedid: 30006432.
• Lee CS, Moy L, Joe BN, Sickles EA, Niell BL. Screening for Breast Cancer in Women Age 75 Years and Older. Ajr Am J Roentgenol. 2018 Feb.210(2):256-263. Pubmedid: 29112471.
• Slanetz PJ, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Niell B, Stuckey AR, Trikha S, Vincoff NS, Weinstein SP, Yepes MM, Newell MS. ACR Appropriateness CriteriaMonitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer. J Am Coll Radiol. 2017 Nov.14(11S):S462-S475. Pubmedid: 29101985.
• Mainiero MB, Moy L, Baron P, Didwania AD, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lee SJ, Lewin AA, Lourenco AP, Nance KJ, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS. ACR Appropriateness Criteria® Breast Cancer Screening. J Am Coll Radiol. 2017 Nov.14(11S):S383-S390. Pubmedid: 29101979.
• Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for Breast Cancer. Radiol Clin North Am. 2017 Nov.55(6):1145-1162. Pubmedid: 28991557.
• Amornsiripanitch N, Mangano M, Niell BL. Screening Mammography: Patient Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk. Ajr Am J Roentgenol. 2017 May.208(5):1163-1170. Pubmedid: 28225643.
• Lee SJ, Trikha S, Moy L, Baron P, diFlorio RM, Green ED, Heller SL, Holbrook AI, Lewin AA, Lourenco AP, Niell BL, Slanetz PJ, Stuckey AR, Vincoff NS, Weinstein SP, Yepes MM, Newell MS. ACR Appropriateness Criteria Evaluation of Nipple Discharge. J Am Coll Radiol. 2017 May.14(5S):S138-S153. Pubmedid: 28473070.
• Wang X, Niell B. Indicator Exploration for Cancers in Women with Neurofibromatosis Type 1 - A Multi-Centre Retrospective Study. J Genet Syndr Gene Ther. 2016 Mar.7(2).
• Freer PE, Niell B, Rafferty EA. Preoperative Tomosynthesis-guided Needle Localization of Mammographically and Sonographically Occult Breast Lesions. Radiology. 2015 May.275(2):377-383. Pubmedid: 25575115.
• Niell BL, Kattapuram T, Halpern EF, Salazar GM, Penzias A, Bonk SS, Forde JC, Hayden E, Sande M, Minehart RD, Gordon JA. Prospective analysis of an interprofessional team training program using high-fidelity simulation of contrast reactions. Ajr Am J Roentgenol. 2015 Jun.204(6):W670-W676. Pubmedid: 26001255.
• Niell BL, Bennett D, Sharma A, Gazelle GS. Extramammary Findings on Breast MR Examinations: Frequency, Clinical Relevance, and Patient Outcomes. Radiology. 2015 Jul.276(1):56-64. Pubmedid: 25584711.
• Niell BL, Gavenonis SC, Motazedi T, Chubiz JC, Halpern EP, Rafferty EA, Lee JM. Auditing a breast MRI practice: performance measures for screening and diagnostic breast MRI. J Am Coll Radiol. 2014 Sep.11(9):883-889. Pubmedid: 24787571. Pmcid: PMC4156888.
• Niell BL, Lee JM, Johansen C, Halpern EF, Rafferty EA. Patient outcomes in canceled MRI-guided breast biopsies. Ajr Am J Roentgenol. 2014 Jan.202(1):223-228. Pubmedid: 24370148. Pmcid: PMC3876032.
• Niell BL, Vartanians VM, Halpern EP. Improving education for the management of contrast reactions: an online didactic model. J Am Coll Radiol. 2014 Feb.11(2):185-192. Pubmedid: 24387957.
• Niell B, Specht M, Rafferty E. Reply: To PMID 22997389. Ajr Am J Roentgenol. 2013 May.200(5):W539. Pubmedid: 23617528.
• Hedegard W, Niell B, Specht M, Winograd J, Rafferty E. Breast reconstruction with a deep inferior epigastric perforator flap: imaging appearances of the normal flap and common complications. Ajr Am J Roentgenol. 2013 Jan.200(1):W75-W84. Pubmedid: 23255774.
• Carter JB, Barnes JA, Niell BL, Nardi V. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy. N Engl J Med. 2013 Aug.369(6):559-569. Pubmedid: 23924007.
• Niell B, Specht M, Gerade B, Rafferty E. Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?. Ajr Am J Roentgenol. 2012 Oct.199(4):929-935. Pubmedid: 22997389.
• Greenwood CM, Sun S, Veenstra J, Hamel N, Niell B, Gruber S, Foulkes WD. How old is this mutation? - a study of three Ashkenazi Jewish founder mutations. BMC Genet. 2010 May.11:39. Pubmedid: 20470408. Pmcid: PMC2889843.
• Niell BL, Rennert G, Bonner JD, Almog R, Tomsho LP, Gruber SB. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst. 2004 Jan.96(1):15-21. Pubmedid: 14709734.
• Niell BL, Long JC, Rennert G, Gruber SB. Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim. Am J Hum Genet. 2003 Dec.73(6):1250-1260. Pubmedid: 14624392. Pmcid: PMC1180391.
• Erson AE, Niell BL, DeMers SK, Rouillard JM, Hanash SM, Petty EM. Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells. Neoplasia. 3(6):521-526. Pubmedid: 11774034. Pmcid: PMC1506561.

• Title: Radiomics and Pathomics to Predict Upstaging of DCIS
  Award Number: 5R01CA249016-05
  Sponsor: National Cancer Institute (NCI)
  Niell, B. (PD/PI), Raghunand, N. (PD/PI)
• Title: Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
  Award Number: 5R01CA257652-05
  Sponsor: National Cancer Institute (NCI)
  Niell, B. (PD/PI)